Aptevo Therapeutics discloses $3.47 million private placement, registers warrant shares for resale

Aptevo Therapeutics Inc. filed a Form D on August 26, 2026 disclosing a securities offering with a first sale date of August 12, 2026. The total offering amount and total amount sold were both listed as $3,472,683, with $0 remaining to be sold.¹ The company reported three investors had already put money into the offering.¹ The offering relied on the Rule 506(c) exemption.¹ Roth Capital Partners, LLC, based in Newport Beach, California, was listed as a sales compensation recipient.¹ Sales commissions were estimated at $315,001, with an additional $90,000 in placement agent expenses.¹

Separately, Aptevo filed a Form S-1 on August 21, 2026 to register resale of warrant-related shares. The prospectus covers up to 6,444,858 shares of common stock issuable upon exercise of pre-funded warrants for up to 861,708 shares, common warrants for up to 4,308,540 shares, and inducement warrants issued to holders of existing warrants for up to 1,274,610 shares.² The pre-funded and common warrants were issued in a private placement under a Securities Purchase Agreement dated August 12, 2026, while the inducement warrants were issued under Warrant Inducement and Reload Letters of the same date.²

Under the inducement letters, holders of existing warrants originally issued in June 2025, April 2025 and December 2024 agreed to exercise those warrants in full for cash at a reduced price of $4.03 per share, in exchange for new inducement warrants at the same $4.03 exercise price.² The same day, Aptevo issued 861,708 unregistered pre-funded warrants along with common warrants for up to 4,308,540 shares, also at $4.03 per share, under the Securities Purchase Agreement.² The company said it received approximately $4.5 million in gross proceeds from the inducement and the concurrent private placement.²

Aptevo will not receive any proceeds from the resale of shares by selling stockholders under the S-1.² Aptevo's common stock trades on the Nasdaq Capital Market under "APVO," and closed at $2.76 per share on August 20, 2026.²